BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26642725)

  • 1. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
    Tanimukai H
    Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
    Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
    JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer.
    Bolton G; Isaacs A
    Psychol Health Med; 2018 Dec; 23(10):1261-1274. PubMed ID: 30048158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
    Oppegaard KR; Mayo SJ; Armstrong TS; Kober KM; Anguera JA; Wright F; Levine JD; Conley YP; Paul S; Cooper B; Miaskowski C
    Nurs Res; 2023 Jul-Aug 01; 72(4):272-280. PubMed ID: 37104681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.
    Mayo SJ; Kuruvilla J; Laister RC; Ayala AP; Alm M; Byker W; Kelly DL; Saligan L
    BMJ Open; 2018 Jan; 8(1):e017578. PubMed ID: 29374660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Changes Related to Cancer Therapy.
    Vannorsdall TD
    Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk factors for cancer-related cognitive impairment: a systematic review.
    Buskbjerg CDR; Amidi A; Demontis D; Nissen ER; Zachariae R
    Acta Oncol; 2019 May; 58(5):537-547. PubMed ID: 30822178
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy-related cognitive impairment.
    Myers JS
    Clin J Oncol Nurs; 2009 Aug; 13(4):413-21. PubMed ID: 19648097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-related cognitive impairment: the breast cancer experience.
    Myers JS
    Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
    Craig CD; Monk BJ; Farley JH; Chase DM
    Support Care Cancer; 2014 Jan; 22(1):279-87. PubMed ID: 24212261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Cognitive Dysfunction in Cancer Survivors.
    Országhová Z; Mego M; Chovanec M
    Front Mol Biosci; 2021; 8():770413. PubMed ID: 34970595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
    Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
    Front Neurol; 2022; 13():777808. PubMed ID: 35401389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, mechanisms, and management of cancer-related cognitive impairment.
    Janelsins MC; Kesler SR; Ahles TA; Morrow GR
    Int Rev Psychiatry; 2014 Feb; 26(1):102-13. PubMed ID: 24716504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-related cognitive impairment in older patients with cancer.
    Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
    J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function after chemotherapy in adults with solid tumours.
    Vardy J; Tannock I
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.